Medaxone (Ceftriaxone)

• Ceftriaxone is a broad‑spectrum cephalosporin used to treat infections caused by susceptible bacteria across several organ systems.
• Community‑acquired pneumonia: effective eradication of the common bacterial pathogens responsible for lower‑respiratory‑tract infection.
• Meningitis: rapid bactericidal activity to clear meningococcal and pneumococcal infections in the central nervous system.
• Gonorrhea: single‑dose therapy to eliminate Neisseria gonorrhoeae strains sensitive to ceftriaxone.
• Urinary tract infections: treatment of complicated and uncomplicated infections caused by Gram‑negative organisms.
• Skin and soft‑tissue infections: resolves cellulitis, abscesses, and wound infections due to susceptible microbes.
• Septicemia: systemic therapy for bloodstream infections with broad bacterial coverage.

• Ceftriaxone inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, thereby blocking the final transpeptidation step of peptidoglycan cross‑linking. This leads to weakened cell walls and osmotic lysis of susceptible Gram‑positive and Gram‑negative organisms, providing a bactericidal effect across a wide spectrum of pathogens.

Ceftriaxone may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Injection site pain or irritation.
• Diarrhea or loose stools.
• Rash or mild skin eruption.
• Nausea or vomiting.
• Elevated liver enzymes.
• Headache.

Serious or Rare Side Effects

• Anaphylaxis or severe hypersensitivity reactions.
• Clostridioides difficile‑associated colitis.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Severe hepatic dysfunction.
• Hemolytic anemia.
• Seizures, especially in patients with renal impairment.

• Ceftriaxone requires careful clinical assessment before use.
• Renal impairment: adjust dosing according to renal function and monitor creatinine.
• Hepatic dysfunction: monitor liver enzymes during therapy.
• Allergy to β‑lactams: avoid use in patients with known hypersensitivity.
• Pregnancy: prescribe only when benefits outweigh potential risks.
• Drug interactions: review concomitant medications for compatibility.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Ceftriaxone can interact with several medicines, requiring attention to compatibility and monitoring.

Major Interactions (Avoid)

• Calcium‑containing IV solutions: may precipitate and cause embolism.
• Aminoglycosides: increased risk of nephrotoxicity.
• Loop diuretics: heightened potential for renal impairment.

Moderate Interactions (Monitor Closely)

• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
• Oral contraceptives: possible reduction in efficacy, advise backup contraception.
• Probenecid: can raise ceftriaxone plasma concentrations, adjust dose if needed.